Permira appoints Erich Hunziker as Senior Adviser to Healthcare team
Permira appoints Erich Hunziker as Senior Adviser to Healthcare team
Permira appoints Erich Hunziker as Senior Adviser to Healthcare team
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Press Rele<strong>as</strong>e<br />
<strong>Permira</strong> <strong>appoints</strong> <strong>Erich</strong> <strong>Hunziker</strong> <strong>as</strong> <strong>Senior</strong><br />
<strong>Adviser</strong> <strong>to</strong> <strong>Healthcare</strong> <strong>team</strong><br />
Enquiries:<br />
<strong>Permira</strong><br />
Noémie de Andia<br />
+44 20 7632 1159<br />
noemie.deandia@permira.com<br />
Matthieu Roussellier<br />
+44 20 7632 1053<br />
matthieu.roussellier@permira.com<br />
Tulchan<br />
Stephen Malthouse<br />
+44 20 7353 4200<br />
smalthouse@tulchangroup.com<br />
Martha Kelly<br />
+44 20 7353 4200<br />
mkelly@tulchangroup.com<br />
4 December 2012 – <strong>Permira</strong> <strong>to</strong>day announces the appointment of <strong>Erich</strong> <strong>Hunziker</strong><br />
<strong>as</strong> a <strong>Senior</strong> <strong>Adviser</strong> <strong>to</strong> the <strong>Healthcare</strong> <strong>team</strong>. <strong>Erich</strong> brings nearly 30 years of<br />
experience of the pharmaceutical industry working in finance, strategy and<br />
management roles.<br />
Most recently <strong>Erich</strong> w<strong>as</strong> Chief Financial Officer and a member of the Executive<br />
Committee of Roche Group („Roche‟). At Roche, <strong>Erich</strong> played a lead role in all<br />
merger and acquisition activity of the Group between 2001 and 2010, including<br />
raising US$48 billion <strong>to</strong> take Genentech private. In addition, under <strong>Erich</strong>‟s<br />
leadership the Roche Venture Fund became a significant inves<strong>to</strong>r in<strong>to</strong> early stage<br />
technologies.<br />
Commenting on the appointment, Mub<strong>as</strong>her Sheikh, Head of <strong>Healthcare</strong> at<br />
<strong>Permira</strong>, said: “We are delighted <strong>to</strong> welcome <strong>Erich</strong> <strong>to</strong> the <strong>Permira</strong> <strong>team</strong>. His depth<br />
of industry experience, and operational and financial expertise, will be invaluable<br />
<strong>as</strong> we continue <strong>to</strong> strengthen our presence in the healthcare sec<strong>to</strong>r.”<br />
<strong>Erich</strong> <strong>Hunziker</strong> added: “I am very ple<strong>as</strong>ed <strong>to</strong> be joining <strong>Permira</strong> <strong>as</strong> a <strong>Senior</strong><br />
<strong>Adviser</strong>. Looking across the global pharmaceutical, med-tech and healthcare<br />
services sub-sec<strong>to</strong>rs it is clear that there are a substantial number of exciting and<br />
attractive investment opportunities. I am looking forward <strong>to</strong> working with Mub<strong>as</strong>her<br />
and the <strong>team</strong> <strong>as</strong> we look <strong>to</strong> take advantage of these opportunities.”
Press Rele<strong>as</strong>e<br />
About <strong>Permira</strong><br />
<strong>Permira</strong> is a European private equity firm with global reach. The <strong>Permira</strong> funds,<br />
raised from pension funds and other institutions, make long-term investments in<br />
companies with the ambition of transforming their performance and driving<br />
sustainable growth.<br />
Founded in 1985, the firm advises funds with a <strong>to</strong>tal committed capital of<br />
approximately €20 billion. Over the p<strong>as</strong>t 27 years the <strong>Permira</strong> funds have made<br />
nearly 200 private equity investments with a focus on driving transformation <strong>to</strong><br />
build better businesses.<br />
<strong>Permira</strong> specialises in five key sec<strong>to</strong>rs: Consumer, Financial Services, <strong>Healthcare</strong>,<br />
Industrials and TMT. The <strong>Permira</strong> funds‟ portfolio currently comprises 24<br />
companies.<br />
The <strong>Permira</strong> Global <strong>Healthcare</strong> <strong>team</strong> w<strong>as</strong> established in 2008. It is led by<br />
Mub<strong>as</strong>her Sheikh who joined from McKinsey in February 2012 and is now 10<br />
people strong. The <strong>Permira</strong> funds are currently invested in Creganna-Tactx<br />
Medical, a leading global provider of outsourced solutions <strong>to</strong> medical devices<br />
companies.<br />
<strong>Permira</strong> employs over 120 professionals b<strong>as</strong>ed in Frankfurt, Guernsey, Hong<br />
Kong, London, Luxembourg, Madrid, Menlo Park, Milan, New York, Paris,<br />
S<strong>to</strong>ckholm and Tokyo. <strong>Permira</strong> endorses the ILPA Private Equity Principles.<br />
For more information visit: www.permira.com<br />
About <strong>Erich</strong> <strong>Hunziker</strong><br />
Career chronology:<br />
2001-2011: Roche Group<br />
Member of the Executive Committee and CFO<br />
CFO and Chief Informatics Officer concurrently<br />
Deputy Head of the Corporate Executive Committee<br />
1997-2001: CEO, Diethelm Keller Group, Switzerland<br />
1997: CFO, Corange Ltd (sold <strong>to</strong> Roche Group)<br />
1988-1997: Boehringer Mannheim<br />
1983-1988: Pharmaceuticals Corange Ltd<br />
1976-1981: Doc<strong>to</strong>ral Thesis, “The his<strong>to</strong>ry of the global build-up of Swiss<br />
Multinational companies”
Change language